GlassScriptPhysician profile
Erika Ryan
NPI 1356698542
$10,182.81
in general payments reported to CMS, 2019-2025
16 companies · $3,730 in 2025
The $3,730 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,812 · 2022: $2,487 · 2023: $1,918 · 2024: $235 · 2025: $3,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,513 · Education: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,512.70 |
| Education | $370.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,066.93 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $1,442.68 | 2021-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,224.63 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $999.22 | 2022-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $690.48 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $509.67 | 2021-2025 | Invega Sustenna |
| Vanda Pharmaceuticals INC. | $496.38 | 2025 | Fanapt |
| Sunovion Pharmaceuticals INC. | $464.98 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $385.16 | 2025 | Cobenfy |
| Alkermes, INC. | $346.90 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Lundbeck LLC | $272.22 | 2023-2025 | Rexulti |
| Axsome Therapeutics, INC. | $146.16 | 2024-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $69.53 | 2025 | Qelbree |
| Corium, LLC | $28.27 | 2023 | Azstarys |
| Indivior INC. | $24.63 | 2025 | Sublocade |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.